Fc Receptors
This volume provides a state-of-the-art update on Fc Receptors (FcRs). It is divided into five parts. Part I, Old and New FcRs, deals with the long-sought-after FcµR and the recently discovered FCRL family and TRIM21. Part II, FcR Signaling, presents a computational model of FcεRI signaling, novel c...
| Συγγραφή απο Οργανισμό/Αρχή: | |
|---|---|
| Άλλοι συγγραφείς: | , |
| Μορφή: | Ηλεκτρονική πηγή Ηλ. βιβλίο |
| Γλώσσα: | English |
| Έκδοση: |
Cham :
Springer International Publishing : Imprint: Springer,
2014.
|
| Σειρά: | Current Topics in Microbiology and Immunology,
382 |
| Θέματα: | |
| Διαθέσιμο Online: | Full Text via HEAL-Link |
Πίνακας περιεχομένων:
- The Old but New IgM Fc Receptor (FcμR)
- Emerging Roles for FCRL Family Members in Lymphocyte Biology and Disease
- Intracellular antibody immunity and the cytosolic Fc receptor TRIM21
- Computational modeling of the main signaling pathways involved in mast cell activation
- Calcium channels in FcR signaling
- Regulation of FcεRI signaling by lipid phosphatases
- Fc Receptors as Adaptive Immunoreceptors
- Glycosylation and Fc Receptors
- Antibodies as natural adjuvants
- IgA, IgA receptors and their anti-inflammatory properties
- Humanized mice to study FcγR function
- FcRn: from molecular interactions to regulation of IgG pharmacokinetics and functions
- Human FcR polymorphism and disease
- Bridging auto-antibodies and arthritis; the role of Fc Receptors
- The FcγR of humans and non-human primates and their interaction with IgG: Implications for induction of inflammation, resistance to infection and the use of therapeutic monoclonal antibodies
- FcgRIIB as a key determinant of agonistic antibody efficacy
- Fc receptor dependent mechanisms of monoclonal antibody therapy of cancer; professionals at work
- Sweet and Sour: The role of glycosylation for the anti-inflammatory activity of immunoglobulin G.
